Suppr超能文献

肠道微生物群——粪便能代表实际情况吗?

The gut microbiome-Does stool represent right?

作者信息

Levitan Orly, Ma Lanying, Giovannelli Donato, Burleson Dawn B, McCaffrey Peter, Vala Ayin, Johnson David A

机构信息

Hygieacare Inc., Norfolk, VA, USA.

Department of Biochemistry and Microbiology, Rutgers University, NJ, USA.

出版信息

Heliyon. 2023 Feb 10;9(3):e13602. doi: 10.1016/j.heliyon.2023.e13602. eCollection 2023 Mar.

Abstract

Many stool-based gut microbiome studies have highlighted the importance of the microbiome. However, we hypothesized that stool is a poor proxy for the inner-colonic microbiome and that studying stool samples may be inadequate to capture the true inner-colonic microbiome. To test this hypothesis, we conducted prospective clinical studies with up to 20 patients undergoing an FDA-cleared gravity-fed colonic lavage without oral purgative pre-consumption. The objective of this study was to present the analysis of inner-colonic microbiota obtained non-invasively during the lavage and how these results differ from stool samples. The inner-colonic samples represented the descending, transverse, and ascending colon. All samples were analyzed for 16S rRNA and shotgun metagenomic sequences. The taxonomic, phylogenetic, and biosynthetic gene cluster analyses showed a distinctive biogeographic gradient and revealed differences between the sample types, especially in the proximal colon. The high percentage of unique information found only in the inner-colonic effluent highlights the importance of these samples and likewise the importance of collecting them using a method that can preserve these distinctive signatures. We proposed that these samples are imperative for developing future biomarkers, targeted therapeutics, and personalized medicine.

摘要

许多基于粪便的肠道微生物群研究都强调了微生物群的重要性。然而,我们推测粪便并不能很好地代表结肠内部的微生物群,研究粪便样本可能不足以捕捉真正的结肠内部微生物群。为了验证这一假设,我们对多达20名患者进行了前瞻性临床研究,这些患者在未预先口服泻药的情况下接受了美国食品药品监督管理局(FDA)批准的重力式结肠灌洗。本研究的目的是展示对灌洗过程中通过非侵入性方式获取的结肠内部微生物群的分析,以及这些结果与粪便样本的差异。结肠内部样本代表降结肠、横结肠和升结肠。所有样本都进行了16S rRNA和鸟枪法宏基因组序列分析。分类学、系统发育和生物合成基因簇分析显示出独特的生物地理梯度,并揭示了样本类型之间的差异,尤其是在近端结肠。仅在结肠内部流出物中发现的高比例独特信息突出了这些样本的重要性,同样也凸显了使用能够保留这些独特特征的方法收集它们的重要性。我们认为这些样本对于开发未来的生物标志物、靶向治疗和个性化医学至关重要。

相似文献

1
The gut microbiome-Does stool represent right?肠道微生物群——粪便能代表实际情况吗?
Heliyon. 2023 Feb 10;9(3):e13602. doi: 10.1016/j.heliyon.2023.e13602. eCollection 2023 Mar.

引用本文的文献

9
Classifying compounds as prebiotics - scientific perspectives and recommendations.将化合物归类为益生元——科学观点与建议。
Nat Rev Gastroenterol Hepatol. 2025 Jan;22(1):54-70. doi: 10.1038/s41575-024-00981-6. Epub 2024 Oct 2.

本文引用的文献

1
Bioaccumulation of therapeutic drugs by human gut bacteria.人类肠道细菌对治疗药物的生物累积。
Nature. 2021 Sep;597(7877):533-538. doi: 10.1038/s41586-021-03891-8. Epub 2021 Sep 8.
2
Gut microbial metabolites as multi-kingdom intermediates.肠道微生物代谢物作为多王国中间产物。
Nat Rev Microbiol. 2021 Feb;19(2):77-94. doi: 10.1038/s41579-020-0438-4. Epub 2020 Sep 23.
4
Nutrition and Cancer in the Microbiome Era.微生物组时代的营养与癌症
Trends Cancer. 2019 Sep;5(9):521-524. doi: 10.1016/j.trecan.2019.07.003. Epub 2019 Aug 6.
5
The Role of the Microbiome in Drug Response.微生物组在药物反应中的作用。
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:417-435. doi: 10.1146/annurev-pharmtox-010919-023612. Epub 2019 Aug 6.
6
Predicting and Understanding the Human Microbiome's Impact on Pharmacology.预测和理解人类微生物组对药理学的影响。
Trends Pharmacol Sci. 2019 Jul;40(7):495-505. doi: 10.1016/j.tips.2019.04.014. Epub 2019 Jun 3.
8
Beyond the census of human gut dwellers.
Nat Rev Microbiol. 2019 Jul;17(7):401. doi: 10.1038/s41579-019-0220-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验